Article Details
Retrieved on: 2024-05-03 14:42:05
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article by Ludwig Burger discusses Roche's product strategy challenges, as CEO Severin Schwan indicates a decline in profits due to reduced COVID-19 product demand. Despite the drop in pandemic-related sales, Roche's pharmaceutical division, under the new leadership of Teresa Graham, aims to compensate with new drugs and bolster their pipeline, amidst an industry-wide downturn, affecting competitors like Siemens Healthineers and GSK as well.
Article found on: uk.movies.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here